Biocryst Pharmaceuticals (BCRX) Non Operating Income (2024 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Non Operating Income came in at -$19.2 million in Q1 2026, up 6.15% YoY from -$18.1 million in Q1 2025, and down 55.32% on a QoQ basis from -$12.4 million in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Non Operating Income (2024 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 3 years of Non Operating Income data on file, last reported at -$19.2 million in Q1 2026.
- Quarterly Non Operating Income rose 6.15% year-over-year to -$19.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$72.3 million (up 14.24% YoY) and the FY2025 annual result came in at -$73.6 million, up 12.81% from the prior year.
- Non Operating Income declined to -$19.2 million in Q1 2026, from -$12.4 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of -$12.4 million in Q4 2025 to a low of -$23.3 million in Q2 2025.
- A 3-year average of -$19.7 million and a median of -$20.5 million in 2024 frame the typical range for Non Operating Income.
- The widest YoY moves for Non Operating Income: up 42.43% in 2025, down 9.58% in 2025.
- Tracing BCRX's Non Operating Income over 3 years: stood at -$21.5 million in 2024, then soared by 42.43% to -$12.4 million in 2025, then tumbled by 55.32% to -$19.2 million in 2026.
- The last three Non Operating Income figures came in at -$19.2 million (Q1 2026), -$12.4 million (Q4 2025), and -$17.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | -18.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.99 Mn |
| Mar 31, 2026 | -19.21 Mn |
| Dec 31, 2025 | -12.37 Mn |
| Sep 30, 2025 | -17.46 Mn |
| Jun 30, 2025 | -23.30 Mn |
| Mar 31, 2025 | -20.47 Mn |
| Dec 31, 2024 | -21.48 Mn |
| Sep 30, 2024 | -21.14 Mn |
| Jun 30, 2024 | -21.26 Mn |
| Mar 31, 2024 | -20.53 Mn |